Evidence map›Paper›PMID 18803968›Full record

ReviewMetabolism: clinical and experimental2008

Synapse formation and cognitive brain development: effect of docosahexaenoic acid and other dietary constituents.

Richard J Wurtman

Abstract readReview
In one paragraph

Review in Metabolism: clinical and experimental, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 2 syntheses or guidelines pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Maternal Dietary Factors and the Risk of Autism Spectrum Disorders: A Systematic Review of Existing Evidence.Autism research : official journal of the International Society for Autism Research · 2020
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Parkinson disease is a fatty acidopathy.Nature reviews. Neurology · 2025
    Review
  7. Review
  8. Article
  9. Role of the gut microbiota in complications after ischemic stroke.Frontiers in cellular and infection microbiology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Richard J WurtmanDepartment of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA 02139, USA. dick@mit.edu
Massachusetts Institute of Technology · US

Funding

PSYCHOPHARMACOLOGICAL EFFECTS OF EXOGENOUS CHOLINER01MH028783 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WURTMAN, RICHARD J · 1985 to 2008
$3.5M
PSYCHOPHARMACOLOGICAL EFFECTS OF EXOGENOUS CHOLINER37MH028783 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI WURTMAN, RICHARD J · 1989 to 1998
–
NIMH NIH HHS MH-28783NIMH NIH HHS R01 MH028783NIMH NIH HHS R37 MH028783
6 · The paper itself

Abstract

The brain is unusual among organs in that the rates of many of its characteristic enzymatic reactions are controlled by the local concentrations of their substrates, which also happen to be nutrients that cross the blood-brain barrier. Thus, for example, brain levels of tryptophan, tyrosine, or choline can control the rates at which neurons synthesize serotonin, dopamine, or acetylcholine, respectively. The rates at which brain cells produce membrane phospholipids such as phosphatidylcholine (PC) are also under such control, both in adult animals and, especially, during early development. If pregnant rats are fed the 3 dietary constituents needed for PC synthesis- docosahexaenoic acid, uridine, and choline-starting 10 days before parturition and continuing for 20 days during nursing, brain levels of PC, and of the other membrane phosphatides (per cell or per mg protein), are increased by 50% or more. In adult animals, this treatment is also known to increase synaptic proteins (eg, synapsin-l, syntaxin-3, GluR-l, PSD-95) but not ubiquitous proteins like beta-tubulin and to increase (by 30% or more) the number of dendritic spines on hippocampal neurons. Docosahexaenoic acid currently is widely used, in human infants, to diminish the negative effects of prematurity on cognitive development. Moreover, docosahexaenoic acid, uridine (as uridine monophosphate), and choline are all found in mother's milk, and included in most infant formulas. It is proposed that these substances are part of a regulatory mechanism through which plasma composition influences brain development.

Indexed as

FoodAnimalsBrainCognitionDendritesDietDocosahexaenoic AcidsFatty Acids, Omega-3Fatty Acids, Omega-6HumansPhospholipidsSynapsesUridineDocosahexaenoic AcidsFatty Acids, Omega-3Fatty Acids, Omega-6PhospholipidsUridine

Identifiers

PMID18803968
PMCPMC2578826
OpenAlexW2144061415

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.